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ABSTRACT 
The present research work was meant to blend some Mannich bases of benzo1,3-diazole dervivatives and was explored for their organic 
exercises. The recently incorporated mixes have been portrayed by their explanatory and unearthly (IR, 1HNMR, Mass spectra) properties. 
Every one of the mixes have been screened for their antifungal exercises by standard strategies. BZ2, BZ3 and BZ6 displayed Promising 
antifungal activity.  
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Benzo1,3-diazole is a bicyclic heterocyclic system consisting 
of two nitrogen atoms and fused phenyl ring. Benzo1,3-
diazole derivatives dervatives take part in a vital role in 
biological fields such as antitubercular, antineoplastic, 
antiviral, antioxidant, anticonvulsant, antiinflammatory, 
antibacterial and antifungal activities. (Kedar M.S et al 2010). 
The synthesis of newer benzimidazole derivatives remains a 
main center of attention of medicinal research 
(Hubschwerlen.C et al  1992). 
latest observations imply that substituted benzo1,3-diazole 
and heterocycles, which are the structural isoster’s of  
nucleotides owing fused heterocyclic nuclei in their 
structures that allow them to interact easily with the 
biopolymers, posses potential activity with lower toxicities 
in the chemotherapeutic approach in man. (Furniss et al 
1996). As an outgrowth of our investigation to discover 
novel antitubercular  and antifungal agents a new series of 1, 
2 disubstituted benzimidazole analogs were synthesized and 
both anti tubercular and anti fungal activity were evaluated. 
2. MATERIALS AND METHOD 
2.1 General 
Melting points (mp) were determined by open capillary tube 
method. The purity  of the compounds was checked on 
precoated TLC plate made of silica Gel-G and spots were 
visualized by iodine Vapour. The IR Spectra of the 
compounds were recorded in the range of 4000-500 cm-1 on 
shimadzu FT-IR, Affinity I, FT - IR spectrometer using KBr 
disc 1HNMR was scanned and chemical shifts are expressed 
in  (ppm) relative to TMS as an internal standard using 
ethanol as solvent Mass Spectra were recorded by EI-MS 
method. 
2.2  Chemistry 
2.2.1 Synthesis of benzo1,3-diazole derivatives 
The different 2-(2 or 5 – substituted) phenyl benzo1,3-
diazole derivatives were prepared as reported in the 
literature. ( Linga S et al 2011). 
2.2.2 Synthesis of  1-{[2-4-methoxyphenyl)- 1-H  
benzimidazol-1-y1]methyl} urea (BZ1) ( Messmary M.A.et al  
2010.) 
Formaldehyde (0.05 mol) was added slowly to 0,05 mol of 2-
( 4-methoxy phenyl ) 1-H Benzimidazole and 0.05 mol of 
urea in 15 ml of ethanol, with continuous stirring for 1 hour 
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and refrigerated overnight. The product was filtered, 
recrystallized using absolute alcohol. 
2.2.3 Synthesis of [2-(4-methoxyphenyl)-1H 
benzimidazol-1-y1] methyl}benzamide( BZ2 ) 
Formaldehyde (0.05mol) was added slowly to 0.05 mol of  2-
(4-methoxyphenyl) 1-H  benzimidazole and 0.05 mol of 
benzamide in 15 ml of ethanol, with continuous stirring for 1 
hour, and refrigerated overnight the product was filtered, 
recrystallized using absolute alcohol. 
2.2.4 Synthesis of N-hydroxy[2-(4-methoxyphenyl) 1-H 
benzimidazole 1-y1] methyl} methanamine  ( BZ3 ) 
Formaldehyde (0.05 mol) was added slowly to 0.05 mol of 2-
(4-methoxy phenyl) 1-H benzimidzole and 0.05 mol of 
hydroxyl amine in 15 mol of ethanol with continuous stirring 
for 1 hour, and refrigerated overnight the product was 
filtered, recrystallized using absolute alcohol. 
2.2.5 Synthesis of 1-{[2-(2-hydroxyphenyl)-1H-
benzimidazol 1-y1]methyl}urea (BZ4) 
Formaldehyde (0.05 mol) was added slowly to 0.05 mol of 2-
(1H-benzimidazol-2-y1) Phenol and 0.05 mol of urea in 15 
ml of ethanol, with continuous stirring for 1 hour and 
refrigerated overnight. The product was filtered, refrigerated 
overnight. The product was filtered, recrystallized using 
absolute alcohol.  
2.2.6 Synthesis of N-{(2-hydroxy phenyl ) -1H-
benzomidazol – 1y1] methyl} benzamide (BZ5) 
Formaldehyde (0.05 mol) was added slowly to 0.05 mol of 2-
(1-H benzimidazol-2-y1) phenol and 0.05 mol of benzamide 
in 15 ml of ethanol, with continuous stirring for 1hour, and 
refrigerated overnight. The product was filtered, 
recrysralized using absolute alcohol. 
2.2.7 Synthesis of N-[(1-hydroxy amino) (BZ6) methyl] 
1H - benzimidazol -2-y1] } Phenol  
Formaldehyde (0.05 mol) was added to 0.05 mol of 2-(1H-
benzimidazol-2-y1) Phenol and 5 m mol of hydroxylamine in 
15 ml of ethanol, with continuous stirring for 1 hour and 
refrigerated overnight. The product was filtered, 
recrystallized using absolute alcohol. 
2.2.8  Synthesis Synthesis of 4-({[2-(2-hydroxy phenyl)-
1H-benzimidazol-1-y1]l} methyl} amino)benzoic acid 
(BZ7) 
Formaldehyde (0.05mol) was added slowly to 0.05 mol of 2-
(1H-benzimidazol-2-y1) Phenol and 0.05 mol of para-amino 
benzoic acid  in 15ml of ethanol, with continuous stirring for 
1 hour, and refrigerated overnight. The product was filtered, 
recrystallized using absolute alcohol.  
2.2.9  Synthesis of 1-{[2-(4-chloro phenyl) 1H-
benzimidazol1-y1] methyl} urea (BZ8) 
Formaldehyde (0.05mol) was added slowly to 0.05 mol of 2-
(4-chlorophenyl) – 1H-benzimidazole and 0.05 mol of urea in 
15 ml of ethanol, with continuous stirring for 1 hour, and 
refrigerated overnight the product was filtered, recrystalized 
using absolute alcohol. 
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Table 1: Derivatives of 1,2-disubstituted Benzo1,3-diazole derivatives 
CODE  STRUCTURES 
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2.3  Spectral data of synthesized  compounds ( BZ1 -BZ8)  
(Silverstein RM., 2011)  
2.3.1     1-{[2-4-methoxyphenyl)- 1-H  benzimidazol-1-
y1]methyl} urea (BZ1) 
IR  ( cm-1 )  : 1678.13 (C=O  amide str) , 3025.34 (aromatic 
C –H str), 2924.89(aliphatic C-H str) , 1259.38(C-O str), 
1323.22(C-N str) 1601.06 (aromatic C=C str) 
1HNMR ( DMSO –d6)  ppm: 
2.3 .2      [2-(4-methoxyphenyl)-1H benzimidazol-1-y1] 
methyl} benzamide( BZ2 ) 
IR  ( cm-1 )  :1652.26 (C = O  amide str) , 3162.31 (aromatic 
C –H str), 2925.83(aliphatic C-H str) ,1297.06(C-O str), 
1622.34 (aromatic C=C str), 1576.54(N-H bend)  
1HNMR ( DMSO –d6)  ppm: 
2.3.3 N-hydroxy[2-(4-methoxyphenyl) 1-H benzimidazole 1-
y1] methyl} methanamine     ( BZ3 ) 
IR ( cm-1) 3402.34 (Secondary amine N.H 
str),3614.23 (O-H str),3337.74 (aromatic C-H Str), 2924.61 
(Aliphatic C-H Str), 1392.46 (C-O Str), 1590.51 (Aromatic 
C=C Str) 7.155 – 8.004 (m, 8H, Ar-H) , 10.311- 10.451                    
(t, 1H,NH) 4.066-4.160(d,2H,CH2) , 5.631(s,2H,NH2) 
0.977(s,3H,CH3)  
1HNMR ( DMSO –d6)  ppm:                            
 2.3 .4      1-{[2-(2-hydroxyphenyl)-1H-benzimidazol 1-
y1]methyl}urea (BZ4)   IR ( cm-1) :  1649.41 (C=O amide 
Str), 1356.25 (C-N Str), 3371.42 (O-H Str in Phenol), 1649 
(C=O amide Str), 3203.49 (Primary aromatic amine N-H 
Str),3024.91 (Aromatic C-H Str), 2923.76 (Aliphatic C-H Str)  
1HNMR ( DMSO –d6)  ppm:  
2.3.5   N-{(2-hydroxy phenyl ) -1H-benzomidazol – 1y1] 
methyl} benzamide (BZ5) IR ( cm-1) : 1645.64 (C=O amide 
Str), 3196.24 (aromatic C=C Str),2924.16 (aliphatic C-H 
Str),1293.29 (C-OStr), 1588.15 (aromatic C=C Str), 3370.00 
(O-H Str in Phenol)1HNMR ( DMSO –d6)  ppm: 
2.3.6  N-[(1-hydroxy amino) (BZ6) methyl] 1H - benzimidazol 
-2-y1] } Phenol  IR ( cm-1): 3371.06 (O-H Str in Phenol), 
3401.32   (Secondary amine N-H Str), 3146.32 (Aromatic C-H 
Str), 2836.92 (Aromatic C-H Str), 1289.06 (C-O Str), 1608.05 
(Aromatic C = C Str) 1323.31 (C-N Str)  1HNMR ( DMSO –d6) 
 ppm: 
2.3.7 4-({[2-(2-hydroxy phenyl)-1H-benzimidazol-1-y1]l} 
methyl} amino)benzoic acid (BZ7) IR ( cm-1): 3370.06 
(Secondary amine N-H Str), 3161.93 (aromatic C-H Str) 
2907.10 (Aliphatic C-H Str), 1294.45 (C-O Str), 1668.24 
(C=NStr), 1598.79 aromatic C=C Str), 923.91 (aromatic C-C 
Str), 1583.24 (C=O Str in carboxylic acids) ,2544.68 (-OH) Str 
in carboxylic acid. 1HNMR ( DMSO –d6)  ppm:   2.3.8   1-{[2-
(4-chloro phenyl) 1H-benzimidazol1-y1] methyl} urea (BZ8)   
IR ( cm-1): 1678.34 (C=O amide Str), 3201.06 (Primary 
aromatic amine N-H Str), 3024.96 (aromatic C-H 
Str),2921.36 (Aliphatic C-H Str), 1262.08 (C-O Str), 1590.52 
(Aromatic C = C Str), 1663.26 (C=N Str ),629.93 (C6H4) 
1057.32(aromatic C-Cl Str)     
   
1HNMR ( DMSO –d6)  ppm: 
3. BIOLOGICAL ACTIVITY  
3.1Evaluation of Antifungal activity against Aspergillus niger 
(Schwalve et al.,2007)           
 Using a loop or swab, the colonies are transferred to the 
plates. The turbidity was visually adjusted with broth to 
equal that of a 0.5 McFarland turbidity standard that had 
been vortexed. Alternatively, the suspension can be 
standardized with a photometric device. A sterile cotton 
swab was dipped into the inoculum, within 15min of 
adjusting the inoculum to McFarland 0.5 turbidity standard 
and was rotated against the wall of the tube above the liquid 
to remove excess inoculum. The entire surface of the agar 
plate was swabbed three times. To ensure even distribution, 
the plates were rotated approximately 600 between 
streaking. To prevent the formation of aerosols, avoid hitting 
the sides of petriplate. The inoculated plates were allowed to 
stand for at least 3 min but no longer than 15min before 
making wells. A hollow tube of 5mm diameter was heated 
and pressed on above the inoculated agar plate and was 
removed immediately. Similarly five wells were made on 
each plate.75ml, 50ml, 25ml, 10ml and 5ml of sample 
solutions were added into respective wells on each plate. 
Plates were incubated within 15 min of sample application. 
Plates were inverted and stacked no more than five high. 
Incubated for 18-24hrs at 370C in an incubator. The plates 
were read only if the lawn of growth was confluent or nearly 
confluent. The diameter of inhibition zone was measured to 
the nearest whole millimetre by holding the measuring 
device 
4. RESULTS AND DISCUSSION 
4.1 Chemistry 
In the present examination, the mannich bases of benzo1,3-
diazole derivatives were planned utilizing CADD, of which 
eight subordinates fulfilling the necessary criteria were 
integrated as portrayed in plot. The physical information of 
all incorporated mixes were given in Table 2. Every one of 
the mixes were cleansed by recrystallization utilizing 
absolute alcohol as dissolvable and the response culmination 
was set up by single spot on TLC plate. The unearthly 
information of orchestrated mixes were described by 
IR,1HNMR and mass phantom examination. 
 
Table 2: Physical data of all synthesized compounds. 
Sl.No Compounds Mol.Formula Mol.wt % Yield m.p (0C) 
1 BZ1 C16 H16N4O2 296.33 72 130-132 
2 BZ2 C22 H19 N3 O2 357.413 81 99-101 
3 BZ3 C15 H15 N3 O2 269.304 70 204-206 
4 BZ4 C15 H15 N4 O2 282.303 64 126-128 
5 BZ5 C21 H 17 N3 O2 343.386 79 100-102 
6 BZ6 C14 H13 N3 O2 233.277 60 207-209 
7  BZ7 C21 H17 N3 O3 359.385 58 163-165 
8  BZ8 C15 H13 N4 OCl 300.749 67 129-131 
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4.2. Antifungal Activity 
4.2.1 Antifungal Screening 
The synthesized compounds were evaluated for its 
antifungal activity against A.niger using Fluconazole 
(50µg/ml) as standard. Compound BZ2,BZ3 and BZ6 showed 
significant Disc Diffusion of 24mm,25mm, 20 mm at a 
concentration of 50µg/ml when compared to other 
compounds. The standard value of Disc Diffusion for 
Fluconazole at 50µg/ml was 24mm. Therefore compounds 
BZ2,BZ3 and BZ6  were found to possess better antifungal 
activity. Result of antifungal screening is depicted in Table 5.
 




    
BZ1 00mm 00mm 00mm 00mm 
BZ2 24 mm 26mm 27mm 29mm 
BZ3 25mm 27mm 29mm 30mm 
BZ4 00mm 00mm 00mm 00mm 
BZ5 00mm 00mm 00mm 00mm 
BZ6 20mm 22mm 24mm 26mm 
 BZ7 00mm 00mm 00mm 00mm 
 BZ8 00mm 00mm 00mm 00mm 




  24 
 
4.2.2   Minimum inhibitory concentration 
The compound BZ6 was found to be sensitive at concentration 0.8 µg/ml. Compound BZ3 showed sensitivity at 3.125 µg/ ml. 
Compound BZ2 showed sensitivity at 1.6 µg/ ml. Standard value of MIC for Fluconazole is 16µg/ml. Result of MIC is given in 
Table5. 
Table 7. MIC in µg/ml of all synthesized compounds 
Fungal 
strain 
Code                                     Concentration (µg/ml) 
100 50 25 12.5 6.25 3.125 1.6 0.8 0.4 0.2 
A.niger BZ2 S S S S S S S R R R 
BZ3 S S S S S S R R R R 
BZ6 S S S S S S S S R R 
S-Sensitive, R- Resistant 
 
5. CONCLUSION 
A new series of maanic bases of 1, 2-disubstituted 
benzimidazole derivaties were synthesized from O-
phenylene diamine starting material.The compounds were 
evaluated for its anti fungal activity.  , compound BZ6 posses 
better anti fungal activity 
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